Fredun Pharmaceuticals

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue145.30160.93213.05228.25267.63
Expenses132.58146.92201.81207.70237.99
EBITDA22.3326.3328.8832.7442.36
EBIT20.4424.5525.7429.1738.43
Profit Before Tax12.7014.0011.2520.5529.65
Net Profit9.4310.4810.7813.1318.57
Financial Ratios
Operating Profit Margin15.55%16.47%13.73%14.37%15.93%
Net Profit Margin6.57%6.55%5.12%5.76%6.99%
Earning Per Share (Diluted)19.9822.1918.2222.1910.92
Dividends Per Share0.000.000.000.000.00